Differential expression of oestrogen receptor and oestrogen inducible genes in gastric mucosa and cancer.
AUTOR(ES)
Singh, S
RESUMO
BACKGROUND: Evidence exists for a role for oestrogen in gastric cancer. The incidence of gastric cancer is much higher in men than in woman, and a similar sex difference is also seen in a rat experimental model of gastric cancer. AIMS: Evidence for a functional oestrogen receptor in normal gastric mucosa and cancer has been sought. METHODS: Oestrogen receptor and the oestrogen inducible genes pS2 and ERD5 were sought by northern blot analysis and in situ hybridisation and immunohistochemistry. Oestrogen receptor protein was studied by enzyme immunoassay. RESULTS: mRNA for oestrogen receptor was detected in cancer and normal gastric mucosa. Enzyme immunoassay for oestrogen receptor showed a mean of 1.8 fmol/mg protein in cancer and 13.7 fmol/mg in paired normal mucosa. The oestrogen inducible genes pS2 and ERD5 were also detected in both cancer and normal mucosa, with expression localised to epithelium. Expression of pS2 was lower in cancer compared with normal mucosa, whereas ERD5 expression was higher in cancer. CONCLUSIONS: Significant amounts of oestrogen receptor were expressed in gastric mucosa with a lower amount in cancer. Oestrogen inducible genes were also expressed differentially but were not found to correlate closely with oestrogen receptor. Oestrogen receptor functionality remains to be demonstrated in the stomach.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1027128Documentos Relacionados
- Absence of pepsinogen A3 gene expression in the gastric mucosa of patients with gastric cancer.
- Immunohistochemical quantitation of oestrogen receptors and proliferative activity in oestrogen receptor positive breast cancer.
- Immunohistochemical and biochemical analysis of the oestrogen regulated protein pS2, and its relation with oestrogen receptor and progesterone receptor in breast cancer.
- Vitamin D receptor expression in colorectal cancer.
- Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer.